Drug Topics
FEBRUARY 3, 2025
Approximately 29% of patients were also more likely to refill their medication, leading investigators to consider an association between medication adherence.
STAT
FEBRUARY 3, 2025
People with celiac disease face a food paradox. Gluten-free bagels, brownie mixes, and frozen burritos beckon from grocery store shelves. Yet despite this abundance, they can’t trust that these foods are actually safe to eat. The story of how the food industry went gaga for gluten-free products, putting the health of people with celiac at risk in the process, takes center stage in Emily Abel’s new book, “Gluten Free for Life: Celiac Disease, Medical Recognition, and the Food
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 3, 2025
In a phase 1b/2a clinical trial, investigators evaluated the once weekly subcutaneous drug for safety, tolerability, pharmacokinetics, and proof-of-concept.
STAT
FEBRUARY 3, 2025
United Therapeutics said Monday that the Food and Drug Administration has cleared it to begin the first clinical trial testing whether organs from gene-edited pigs could provide a viable option for patients in dire need of an organ transplant. Over the last three years, United and a rival company, eGenesis, have transplanted genetically modified pig hearts or kidneys into several patients, but those procedures were done through compassionate use waivers from the FDA that allow doctors to treat i
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 3, 2025
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to explore ultra-high-cost drugs and pharmacists role in managing patients prescription regimens.
STAT
FEBRUARY 3, 2025
Is China setting the global standard for AI-driven drug development? DeepSeek, a relatively unknown AI firm based in Hangzhou, China, shocked the industry last week with claims that its technology could rival the abilities of technologies developed by leading U.S. AI companies — and do so far more economically. The claims ignited debates not just about the implications for AI companies like OpenAI but for the U.S. drug industry, which is increasingly turning to AI in hopes of develop
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 3, 2025
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. The most sustainable, and personally meaningful, way to fund journalism is through viewers like you. STAT is running a 50% discount right now. If it makes sense for you financially, think about it. This newsletter and my inbox are always here for you, too: bob.herman@statnews.com.
European Pharmaceutical Review
FEBRUARY 3, 2025
The US Food and Drug Administration (FDA) has sent a warning letter to KVK-Techs drug manufacturing facility following an inspection in April 2019. The document identified significant violations of current good manufacturing practice (cGMP) regulations for finished pharmaceuticals. The FDA issued the warning letter to KVK-Tech in February 2020, advising that due to these cGMP breaches, the companys products are adulterated according to the Federal Food, Drug, and Cosmetic Act (FD&C Act).
STAT
FEBRUARY 3, 2025
Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation for cervical cancer screening for high-risk genotypes of human papillomavirus (HPV), including the use of self-collection tests. The move follows the Food and Drug Administration’s approval of self-collection tests last summer.
PharmaVoice
FEBRUARY 3, 2025
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 3, 2025
To many, Robert F. Kennedy Jr. appears to advocate positions that are contrary to scientific orthodoxy, but there’s one area where he and his critics largely agree: Healthier eating leads to a healthier population. Obesity, for instance, is a major and costly health problem that is only getting worse. Excess body fat and obesity are linked to type 2 diabetes, coronary artery disease, and hypertension, among other ailments.
Pharmacy Times
FEBRUARY 3, 2025
Rising seasonal viruses and emerging concerns emphasize the need for public awareness and prevention.
STAT
FEBRUARY 3, 2025
Vaccines do not cause autism. You’ve almost certainly read that before — probably hundreds of times. But many people do not believe it, perhaps because too often it is repeated without a real explanation of how we know that. So here is an attempt to offer that explanation.
Pharmacy Times
FEBRUARY 3, 2025
The phase 1b/2a results show the potential of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
FEBRUARY 3, 2025
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
European Pharmaceutical Review
FEBRUARY 3, 2025
What are the top trends or recent developments relating to upstream processing? Upstream processing of mammalian cell culture has seen several significant trends and advances in recent years, following demand for lower cost of goods (CoGs), higher flexibility and more environmental sustainability. Top trends and recent developments in the fieldinclude: Single-use technologies : Single-use bioreactors and other disposable components are becoming increasingly popular.
Fierce Healthcare
FEBRUARY 3, 2025
Most hospital finance executives surveyed said they will need to shift increased costs onto insurers and patients in the form of higher service charges.
Pharmacy Times
FEBRUARY 3, 2025
Topical, targeted drug delivery increases drug concentrations at the desired site while also reducing toxicity and unwanted adverse effects.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmafile
FEBRUARY 3, 2025
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond.
Pharmacy Times
FEBRUARY 3, 2025
Many patients do not attain sufficient disease control with inhaled corticosteroids in combination with long-acting -2 agonists and remain vulnerable to exacerbations.
STAT
FEBRUARY 3, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! There’s a lot going on. As a reminder, you can submit comments and news tips to STAT on our site , or to any reporter via email, social media, or Signal. (I’m theresagaff.96 there.
Pharmacy Times
FEBRUARY 3, 2025
Antiviral treatments can accelerate healing and reduce complications.
Fierce Healthcare
FEBRUARY 3, 2025
Moody's Ratings is downgrading the insurance industry's credit outlook to negative as elevated medical costs continue to batter payers. | Moody's Ratings is downgrading the insurance industry's credit outlook to negative as elevated medical costs continue to batter payers.
Pharmacy Times
FEBRUARY 3, 2025
Three experts from UPMC Health Plan highlight the importance of treating patients physical, mental, and social health when managing diabetes, rather than the disease alone.
Pharmaceutical Technology
FEBRUARY 3, 2025
Sanofi has received Chinas NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating adults with NDMM.
PhRMA
FEBRUARY 3, 2025
Every day, biopharmaceutical researchers in our industry are focused on developing the medicines that patients need to prevent and treat disease. This means taking a comprehensive approach to health care, with a focus on prevention, screening and early intervention, health and wellness and building on our scientific knowledge to develop the next generation of treatments and cures.
Fierce Healthcare
FEBRUARY 3, 2025
Cigna is officially kicking off a multiyear effort designed to "meaningfully" change the experience of its members. | Cigna is officially kicking off a multiyear effort designed to "meaningfully" change the experience of its members.
Pharmaceutical Technology
FEBRUARY 3, 2025
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Pharmacy Times
FEBRUARY 3, 2025
Health care professionals, particularly pharmacists, can recommend that patients take over-the-counter supplements, such as melatonin, to facilitate REM sleep.
The Guardian - Pharmaceutical Industry
FEBRUARY 3, 2025
Regulators to tighten up criteria after concerns over inappropriate private prescriptions of popular drugs Access to weight-loss jabs through online pharmacies is to be tightened up as part of a crackdown on inappropriate prescriptions although some experts say even more must be done. Weight-loss injections such as Wegovy, which contains the drug semaglutide, and Mounjaro, which contains the drug tirzepatide, have boomed in popularity after trials showed they can help people lose significant am
Fierce Healthcare
FEBRUARY 3, 2025
In an era of increasing pressure on emergency departments, the role of interoperability has never been more crucial. | CMO Dr. Hamad Husainy discusses how interoperability and pushed data delivery are transforming emergency departments and improving patient care.
The Guardian - Pharmaceutical Industry
FEBRUARY 3, 2025
It seems bizarre that ministers and UKs largest company cannot complete investment in vital life sciences sector The announcement in March last year that AstraZeneca would be investing 450m to expand its vaccine plant in Speke in Liverpool was presented in full flag-waving style by the company and the government of the day. Sir Pascal Soriot, the AstraZeneca chief executive, reflected it had been 25 years since the merger of Astra of Sweden and Zeneca of the UK; the firm was now truly global but
Fierce Healthcare
FEBRUARY 3, 2025
Zoom Ventures. the investment arm of Zoom Communications, invested in Suki, while Allara Health picked up $26 million in series B funding and Bicycle Health, a provider of virtual opioid use disorder treatment, collected $16.5 million.
Expert insights. Personalized for you.
441 
Let's personalize your content